The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

Chowdhury, Rasheduzzaman, Yeoh, Kar Kheng, Tian, Ya‐Min, Hillringhaus, Lars, Bagg, Eleanor A, Rose, Nathan R, Leung, Ivanhoe K H, Li, Xuan S +10 more·2011·The EMBO Reports
DOI 10.1038/embor.2011.43

Cited by (1,000)

Items 901–1,000 of 1,000

  1. mTOR Modulation Induces Selective Perturbations in Histone Methylation Which Influence the Anti-Proliferative Effects of mTOR Inhibitors
    HaEun Kim, Benjamin Lebeau, David J. Papadopoli, Predrag Jovanović, Mariana De Sa Tavares Russo, Daina Zofija Avizonis, Masahiro Morita, Farzaneh Afzali, Josie Ursini‐Siegel, Lynne-Marie M Postovit et al. · 2023 · SSRN Electronic Journal
  2. Understanding and imaging PHGDH-driven intrinsic resistance to mutant IDH inhibition in gliomas
    Céline Taglang, Georgios Batsios, Anne Marie Gillespie, Joanna J. Phillips, Jennie Webster Taylor, Pavithra Viswanath · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  3. IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosis
    Angeliki Mela, Abby L. Brand, Aayushi Mahajan, Athanassios Dovas, Nelson Humala, Smriti Kanangat, Allison Kleinstein, Sandra Leskinen, Trang Tt Nguyen, Qiuqiang Gao et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Design, synthesis and biological evaluation of small molecules as modulators of histone methyltransferases and demethylases
    Stefano Tomassi · 2014
  5. Histone Code Modulation by Oncogenic PWWP-Domain Protein in Breast Cancers
    Zeng-Quan Yang · 2010
  6. Molecular regulation and analysis of neural stem and cancer cell characteristics
    Amilcar Reis · 2012 · Figshare
  7. IDH1 AND IDH2 GENE MUTATIONS IN SOUTH AFRICAN PATIENTS WITH CYTOGENETICALLY-NORMAL ACUTE MYELOID LEUKAEMIA
    Ashleigh Helen Walton · 2013 · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
  8. Epigenetic basis for the oncogenic potential of IDH mutations
    Chao Lü · 2013
  9. A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody
    Andreas G. Bader, David Brown, Matthew Winkler, Eun‐Hee Shim, Carolina Becker Livi, Dinesh Rakheja, Jubilee C. Tan, Daniel G. Benson, Vishwas Parekh, Eun-Young Kho et al. · 2014
  10. Development and Evaluation of Chemical Probes for the Study of Histone Demethylases
    Laura J. Marholz · 2015 · CU Scholar (University of Colorado Boulder)
  11. Synthesis and Application of Cell-Permeable Metabolites for Modulating Chromatin Modifications Regulated by α-Ketoglutarate-Dependent Enzymes
    Hunter Balduf, Antonella Pepe, Ann L. Kirchmaier · 2016 · Methods in pharmacology and toxicology
  12. Tumor-Specific Approach: Oligodendroglioma (IDH1 Mutated, 1p/19q Deleted)
    Charles Marc Leyrer, Erin Sennett Murphy, Manmeet Singh Ahluwalia · 2016 · Springer eBooks
  13. Epigenetic Changes in Gliomas
    Vinay K. Puduvalli · 2014 · Springer eBooks
  14. Metabolic Feedback Control through H3K4 Demethylation
    Maria Soloveychik · 2016 · TSpace (University of Toronto)
  15. The Genomics of Diffuse Low-Grade Gliomas
    Maleeha F. Ahmad, Robert John Weil, Nicholas F. Marko · 2017 · Springer eBooks
  16. The Adaptor Protein p66SHC: Roles in Cell Signaling, Metabolism and Growth
    Mohamed A. Soliman · 2014 · TSpace (University of Toronto)
  17. Energy Metabolism and Epigenetics
    Scott J. Bultman · 2017 · Springer eBooks
  18. Molecular Drivers in Chondrosarcoma
    Yvonne de Jong, Judith V.M.G. Bovée · 2017 · Elsevier eBooks
  19. Mitochondria Remodeling in Cancer
    Kenneth J. Dornfeld, Andrew J. Skildum · 2018 · Springer eBooks
  20. [Bite marks as evidence in violent incidents, rapes and murders. Report of 2 cases].
    C. Stavrianos, K Hourdakis · 1989 · PubMed
  21. Proof Delivery Form
    Munehiro Uda Fumiyuki Yamakura · 2012
  22. Exploring Clinical and Biological Subtypes of Isocitrate Dehydrogenase Mutant Gliomas
    Romina Nejad · 2018 · TSpace (University of Toronto)
  23. Tumorigenesis and Metabolism Disorder
    Fan Yang, Le Shu, Xiaobo Zhang · 2019 · Springer eBooks
  24. DNA damage, repair and mutational spectrum
    Ke Bian · 2019
  25. The Effect of Cancer-Associated SETD2 Mutations on Transcription and Chromatin Organization
    Catherine C. Fahey · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  26. Attaining Epigenetic Rejuvenation: Challenges Ahead
    Jogeswar Satchidananda Purohit, Neetika Singh, Shah Saddad Hussain, Madan Mohan Chaturvedi · 2020 · Springer eBooks
  27. A fluorescent l-2-hydroxyglutarate biosensor
    Zhaoqi Kang, Manman Zhang, Kaiyu Gao, Wen Zhang, Yidong Liu, Dan Xiao, Shiting Guo, Cuiqing Ma, Chao Gao, Ping Xu · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  28. DNA methylation and survival differences associated with the type of IDH mutation in 1p/19q non-codeleted astrocytomas
    C. Mircea S. Tesileanu, Wies Vallentgoed, Marc Sanson, Walter Taal, Paul M. Clément, Wolfgang Wick, Alba Ariela Brandes, Jean Français Baurain, Olivier Louis Chinot, Helen Wheeler et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Angioimmunoblastic T‐cell Lymphoma
    Jehan Dupuis, Franck Morschhauser · 2021
  30. Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression
    Kevin P. Kotredes · 2015 · TUScholarShare (Temple University)
  31. Immunohistochemical classification of diffuse gliomas. Doctoral Thesis
    Arvīds Jakovļevs · 2021
  32. Clinical utility of solid tumor epigenetics
    Engin Demirdizen, Julián Taranda, Şevin Turcan · 2021 · Elsevier eBooks
  33. Epigenetic heterogeneity in primary bone cancers
    Peter Peneder, Eleni M. Tomazou, Marcus Tötzl · 2021 · Elsevier eBooks
  34. Synthesis and Evaluation of 3-(Indol-3-yl)-4-(Pyrazolo[3,4-c]Pyridazin-3-yl)-Maleimides as Potent Mutant Isocitrate Dehydrogenase-1 Inhibitors
    J.H. Xu, Yuanyuan Hu, Xiaoqi Liu, Anhui Gao, Lixin Gao, Lei Xu, Yubo Zhou, Jianrong Gao, Qing Ye, Chunqi Hu et al. · 2021 · Pharmaceutical Chemistry Journal
  35. Validity of maternal-reported weight and height of 2-5 year old children (Scientific Letter)
    Rati Jani, Seema Mihrshahi, Subhadra Mandalika, Kimberley Margaret Mallan · 2014 · QUT ePrints (Queensland University of Technology)
  36. Aggiornamenti sulla prima fase di Capua
    Werner Johannowsky · 2025 · Annali di archeologia e storia antica
  37. Faculty Opinions recommendation of Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.
    Taina A. Pihlajaniemi · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  38. Faculty Opinions recommendation of Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.
    Josef T. Prchal · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  39. Faculty Opinions recommendation of Control of endothelial quiescence by FOXO-regulated metabolites.
    Navdeep S. Chandel · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  40. Energy Metabolism and Epigenetics
    Scott J. Bultman · 2019 · Springer eBooks
  41. Ultimate Precision: Targeting Cancer But Not Normal Self-Replication
    Vamsidhar Velcheti, David S. Schrump, Yogen Saunthararajah · 2021 · Current cancer research
  42. Faculty Opinions recommendation of Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.
    Wafik S. El‐Deiry, Pieter van den Heuvel · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  43. Faculty Opinions recommendation of IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.
    Keith Adam Choate · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  44. Biochemical and Genetic Markers in Neurological Trauma and Tumors: Review Article
    Omyma Ashraf, Tahia Hashim Saleem, Bakheet Elsadek, Ali Rabee Kamel Hamdan, Mohammed H. Hassan · 2022 · Asian Journal of Biochemistry Genetics and Molecular Biology
  45. Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles
    Tan Zhang, Liqun Yuan, Minfeng Sheng, Yanming Chen, Ji Wang, Qing Lan · 2022 · Frontiers in Oncology
  46. Oncometabolites, epigenetic marks, and DNA repair
    Jonathan Dow, Peter M. Glazer · 2022 · Elsevier eBooks
  47. Renal Cell Carcinoma - Recent Advances, New Perspectives and Applications
    Jindong Chen · 2022 · IntechOpen eBooks
  48. Rewiring of Drug Metabolism and Its Cross‐talk with Metabolic Reprogramming in Cancer
    Subhabrata Majumder, Soumen K. Manna · 2022 · Wiley eBooks
  49. Genomic profiles of IDH-mutant gliomas: MYCN amplified IDH-mutant astrocytoma had the worst prognosis and true mixed oligoastrocytoma does not exist
    Kwang-Hoon Lee, Seong‐Ik Kim, Eric Eunshik Kim, Yumi Shim, Jae‐Kyung Won, Chul‐Kee Park, Seung Hong Choi, Hongseok Yun, Hyunju Lee, Sung‐Hye Park · 2022 · Research Square
  50. BCL6 is a context-dependent mediator of the glioblastoma therapy response
    Anna K.W. Tribe · 2023
  51. [Clinical analysis of the combination regimen with Bcl-2 inhibitor venetoclax in the treatment of 30 cases of acute myeloid leukemia with IDH1/2 mutation].
    X Wang, Xiebing Bao, J Zhang, Baoquan Song, M Y Li, Jundan Xie, Hongjie Shen, Depei Wu, Huiying Qiu · 2022 · PubMed Central
  52. Data from Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer
    Vineet Kumar Gupta, Nikita Sharma, Brittany C. Durden, Vanessa T. Garrido, Kousik Kesh, Dujon Edwards, Dezhen Wang, Ciara Myer, Beatriz Mateo-Victoriano, Sai Sundeep Kollala et al. · 2023
  53. Data from Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
    Sam Garnett, Angeline de Bruyns, Veronique Provencher-Tom, Kendall Dutchak, Ran Shu, David L. Dankort · 2023
  54. Data from Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
    Sam Garnett, Angeline de Bruyns, Veronique Provencher-Tom, Kendall Dutchak, Ran Shu, David L. Dankort · 2023
  55. Methylation and hydroxymethylation in cancer
    Fazila Asmar, Linn Gillberg, Kirsten Grønbæk · 2023 · Elsevier eBooks
  56. Blockage L2HGDH-Mediated S-2HG Catabolism Orchestrates Macrophage Polarization to Elicit Antitumor Immunity
    Shuang Feng, Xianjing Li, Shi Huang, Yanyan Jin, Tong Liang, Xiuli Du, Luoyi Zhuo, Chun Shan, Wenbo Zhang, Wei Yue Sun et al. · 2023 · SSRN Electronic Journal
  57. Modeling the Earliest Stages of Gliomagenesis Using Human iPSC-derived NPCs in A Three-dimensional Alginatebased Matrix
    Burcu Ekinci, Tutku Yaraş, Yavuz Oktay · 2023 · The Anatolian Journal of General Medical Research
  58. Potential Correlation between Gene Mutations and Metabolic Changes in Acute Myeloid Leukemia
    Aili Jiang, Zhiying Hou, Bingyan Yu, Ning Wang, Bin Zhang · 2024 · The Natural Products Journal
  59. Catalytically distinct IDH1 mutants tune phenotype severity in tumor models
    Mowaffaq Adam Ahmed Adam, Mikella Robinson, Ashley V. Schwartz, Grace A. Wells, An D. Hoang, Elene Albekioni, Cecilia Gallo, Grace Chao, Joi L. Weeks, Giovanni Quichocho et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Branched chain α-ketoacids aerobically activate HIF1α signaling in vascular cells
    Wusheng Xiao, Nishith M. Shrimali, William M. Oldham, Clary B. Clish, Huamei He, Samantha J. Wong, Bradley M. Wertheim, Elena Arons, Marcia C. Haigis, Jane A. Leopold et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Advances in DNA Methylation in Peripheral T Cell Lymphoma
    向慧 张 · 2024 · Advances in Clinical Medicine
  62. Desarrollo de una plataforma de baculovirus recombinantes destinados a la expresión de múltiples genes terapéuticos en células de mamífero
    Leslie C. Amorós Morales · 2024
  63. Mitochondria as a Key Player in Cancer
    Beáta Čižmárová, Beáta Hubková, Andrea Grešová, Vladimír Kraus, Anna Birková · 2024 · Interdisciplinary cancer research
  64. Working towards understanding the natural history and treatment response of noncanonical IDH mutant astrocytomas
    Alexandre Roux, Tariq Al Saadi, Michael Luo, Phuong Uyen Le, Roberto Jose Diaz, Kevin Petrecca · 2024 · Neurochirurgie
  65. Discovery of FT-2102 (olutasidenib), an inhibitor of mutant isocitrate dehydrogenase 1, for treatment of relapsed or refractory acute myeloid leukemia
    Xin Li, Yongcheng Song · 2024 · Elsevier eBooks
  66. Cellular Regulation and Oncogenesis of Primary Tumors in the Central Nervous System
    Leonnardo Altoé Miranda Lemos, Caroline Stadler, Izabelly Constantinov Lemos, Junio Pereira Pardins, Victoria Beatriz Podolan Sauka · 2024 · Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery
  67. Application of ¹H NMR-based metabolomics in childhood leukemia. A preliminary study.
    Agata Serrafi, Małgorzata Pupek, Łukasz Lewandowski, Anna Janicka-Kłos, Tomasz Niedziela, Andrzej Wasilewski, Adrian Kasprzak, Agnieszka Matera-Witkiewicz, Tomasz Zatoński, Katarzyna Połtyn–Zaradna et al. · 2025 · Research Square
  68. Mutant IDH impairs chromatin binding by PDGFB to promote chromosome instability
    Rachel Naomi Curry, Malcolm F. McDonald, Peihao He, Brittney Lozzi, Yeunjung Ko, Isabella O’Reilly, Anna Rosenbaum, Wookbong Kwon, Leyla E. Fahim, Joshua M. Marcus et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Leucémies aigües myéloïdes avec mutations IDH1/2
    Ludovic Gabellier, Enzo Bosetta, Maël Heiblig, Jean‐Emmanuel Sarry · 2025 · médecine/sciences
  70. New alleles of D-2-hydroxyglutarate dehydrogenase enable studies of oncometabolite function in Drosophila melanogaster
    Madhulika Rai, Prince Okah, Shefali A. Shefali, Alexander J. Fitt, Miaozhong Shen, Mandkhai Molomjamts, Robert H. Pepin, Travis G. Nemkov, Angelo D’Alessandro, Jason M. Tennessen · 2025 · G3 Genes Genomes Genetics
  71. Mitochondrial molecule has unexpected role in tissue healing
    Ram Prosad Chakrabarty, Navdeep S. Chandel · 2025 · Nature
  72. Epigenetic reprogramming induced by key metabolite depletion is an evolutionarily ancient path to tumorigenesis
    Zhe Chen, Xiaomeng Zhang, Mingxi Deng, Chongyang Li, Thi Thuy Nguyen, Min Liu, Kun Dou, Toyotaka Ishibashi, Jiguang Wang, Yan Yan · 2025 · Disease Models & Mechanisms
  73. Impact of IDH Mutations on Ligand Unbinding: Insights from Steered Molecular Dynamics
    Alka Singh, Sonia Kumari, Masilamani Elizabeth Sobhia · 2025 · Current Topics in Medicinal Chemistry
  74. Mitochondria and redox homeostasis - the backseat drivers in glioma
    Shruti Patrick, Ellora Sen · 2025 · Free Radical Research
  75. Epigenetic Reprogramming Induced by Acetyl-CoA and SAM Depletion is an Evolutionarily-ancient Path to Malignant Growth
    Zhe Chen, Xiaomeng Zhang, Mingxi Deng, Chongyang Li, Thi Thuy Nguyen, Min Liu, Kun Dou, Toyotaka Ishibashi, Jiguang Wang, Yan Yan · 2025
  76. Lysine- R 2HGylation identified as a post-translational modification in R 2HG-elevated cancers
    Qian Zhao, Peiwu Huang, Changhao Yuan, Peng Xia, Qiang‐Shuai Gu, Tonghua Yang, Xiang Li, Ruijun Tian, Dan Yang · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Additional file 3 of Targeting phosphoglycerate dehydrogenase in multiple myeloma
    Samah Elsaadi, Ida Johnsen Steiro, Abdollahi, Pegah, Esten N. Vandsemb, Yang, Rui, Tobias Schmidt Slørdahl, Torstein Baade Rø, Eline Menu, Sponaas, Anne-Marit, Magne Børset · 2021 · Figshare
  78. Additional file 20 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  79. Additional file 5 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  80. Additional file 16 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  81. Additional file 4 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  82. Additional file 19 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  83. Additional file 1 of Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
    Hsiao P. J. Voon, Linda L. Hii, Andrew Garvie, Maheshi Udugama, Brian Krug, Caterina Russo, Anderly C. Chüeh, Roger J. Daly, Alison E. Morey, Toby D. M. Bell et al. · 2023 · Figshare
  84. Additional file 2 of Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
    Hsiao P. J. Voon, Linda L. Hii, Andrew Garvie, Maheshi Udugama, Brian Krug, Caterina Russo, Anderly C. Chüeh, Roger J. Daly, Alison E. Morey, Toby D. M. Bell et al. · 2024 · Figshare
  85. Additional file 4 of Targeting phosphoglycerate dehydrogenase in multiple myeloma
    Samah Elsaadi, Ida Johnsen Steiro, Abdollahi, Pegah, Esten N. Vandsemb, Yang, Rui, Tobias Schmidt Slørdahl, Torstein Baade Rø, Eline Menu, Sponaas, Anne-Marit, Magne Børset · 2021 · Figshare
  86. Additional file 1 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2023 · Figshare
  87. Additional file 3 of Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
    Hsiao P. J. Voon, Linda L. Hii, Andrew Garvie, Maheshi Udugama, Brian Krug, Caterina Russo, Anderly C. Chüeh, Roger J. Daly, Alison E. Morey, Toby D. M. Bell et al. · 2024 · Figshare
  88. Additional file 11 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  89. Additional file 8 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  90. Additional file 13 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  91. Additional file 14 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  92. Additional file 1 of Targeting phosphoglycerate dehydrogenase in multiple myeloma
    Samah Elsaadi, Ida Johnsen Steiro, Abdollahi, Pegah, Esten N. Vandsemb, Yang, Rui, Tobias Schmidt Slørdahl, Torstein Baade Rø, Eline Menu, Sponaas, Anne-Marit, Magne Børset · 2021 · Figshare
  93. Additional file 9 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  94. Additional file 6 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  95. Additional file 15 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  96. Additional file 21 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  97. Additional file 18 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  98. Additional file 12 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  99. Additional file 17 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare
  100. Additional file 3 of A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
    Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Michelle Fishbein, Noberini, Roberta, Ioannis N. Anastopoulos, Nicola Tufton, Eugénie S. Lim, Rupert Obholzer, Johnathan Hubbard et al. · 2024 · Figshare